The COVID-globulin medicine against coronavirus based on convalescent blood plasma has successfully passed clinical trials and received a permanent certification by the Russian Health...
The Ministry of Health of the Russian Federation has included the injectable form of the direct-acting antiviral drug Areplivir® (favipiravir) in the updated, fourteenth, version...
New Russian vaccine against the coronavirus, Convacell, can be registered before the end of the first quarter of 2022, head of the Federal Bio-Medical...
The vaccine, called spike ferritin nanoparticle (SpFN), stands out in the COVID-19 vaccine landscape. Scientists developed a nanoparticle vaccine, based on a ferritin platform,...
ChemRar Group announces the Russian Avifavir® (INN: favipiravir) drug is effective against various variants of SARS-CoV-2 (coronavirus), including Delta and Omicron, as it affects...
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the U.S. Food and Drug Administration (FDA) has...